References
- Bersinger NA, Wunder DM, Birkhäuser MH, Mueller MD. 2008. Gene expression in cultured endometrium from women with different outcomes following IVF. Molecular Human Reproduction 14:475–484.
- Binart N, Bachelot A, Bouilly J. 2010. Impact of prolactin receptor isoforms on reproduction. Trends in Endocrinology Metabolism 21:362–368.
- Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver R, Kwak J, et al. 1997. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Clinical Guidelines Recommendation Committee for Diagnosis and Treatment of Recurrent Spontaneous Abortion. American Journal of Reproductive Immunology 38:57–74.
- Garzia E, Borgato S, Cozzi V, Doi P, Bulfamante G, Persani L, et al. 2004. Lack of expression of endometrial prolactin in early implantation failure: a pilot study. Human Reproduction (Oxford, England) 19:1911–1916.
- Hanna CW, Bretherick KL, Liu CC, Stephenson MD, Robinson WP. 2010. Genetic variation within the hypothalamus-pituitary-ovarian axis in women with recurrent miscarriage. Human Reproduction (Oxford, England) 25:2664–2671.
- Hu ZZ, Zhuang L, Meng J, Leondires M, Dufau ML. 1999. The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP (N). Journal of Clinical Endocrinology and Metabolism 84:1153–1156.
- Hu ZZ, Zhuang L, Meng J, Tsai-Morris CH, Dufau ML. 2002. Complex 5’ genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization. Endocrinology 143:2139–2142.
- Jabbour HN, Critchley HO, Boddy SC. 1998. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. The Journal of Clinical Endocrinology and Metabolism 83:2545–2553.
- Jones RL, Critchley HO, Brooks J, Jabbour HN, McNeilly AS. 1998. Localization and temporal expression of prolactin receptor in human endometrium. The Journal of Clinical Endocrinology and Metabolism 83:258–262.
- Kim JJ, Choi YM, Lee SK, Yang KM, Paik EC, Jeong HJ, et al. 2014. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study. American Journal of Reproductive Immunology 72:571–576.
- Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, et al. 1997. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes and Development 11:167–178.
- Park CW, Han AR, Kwak-Kim J, Park SY, Han JY, Koong MK, et al. 2011. The role of methylenetetrahydrofolate reductase C677T polymorphism on the peripheral blood natural killer cell proportion in women with unexplained recurrent miscarriages. Clinical and Experimental Reproductive Medicine 38:168–173.
- Practice Committee of the American Society for Reproductive Medicine. 2013. Definitions of infertility and recurrent pregnancy loss a committee opinion. Fertility and Sterility 99:63.
- Smith ZD, Meissner A. 2013. DNA methylation: roles in mammalian development. Nature Reviews Genetics 14:204–220.
- Vlahos NP, Bugg EM, Shamblott MJ, Phelps JY, Gearhart JD, Zacur HA. 2001. Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells. Molecular Human Reproduction 7:1033–1038.
- Wu WX, Brooks J, Glasier AF, McNeilly AS. 1995. The relationship between decidualization and prolactin mRNA and production at different stages of human pregnancy. Journal of Molecular Endocrinology 14:255–261.